Development and Validation of the Brief Support Group Leader Self‐Efficacy Scale Among Scleroderma Peer Support Group Leaders

Key Points

• The central aim is to develop and validate a brief scale assessing self-efficacy for support group leaders in the scleroderma community.
• Development of a 6-item self-efficacy scale.
• Comparison of measurement properties with the full SGLSS.
• Implementation of validation tests to assess reliability and validity.
• The 6-item scale is found to have similar measurement properties to the original scale.
• It is notably shorter and more feasible for practical use.